Global Antiparasitic Drugs Market Size (2024 - 2029)

Antiparasitic Drugs Market Analysis

The Global Antiparasitic Drugs Market size is estimated at USD 24.61 billion in 2024, and is expected to reach USD 32.20 billion by 2029, growing at a CAGR of 5.53% during the forecast period (2024-2029).

The antiparasitic drugs market is a crucial pharmaceutical industry segment, primarily focused on medications that treat infections caused by parasites such as worms, protozoa, and ectoparasites. The significant factors contributing to the growth of the antiparasitic drugs market include the increasing prevalence of parasitic infections, the surge in research and development activities of companies to launch antiparasitic drugs, and the initiatives taken by the government and non-profit groups to raise public awareness regarding parasitic infections and provide appropriate treatment.

For instance, according to the World Health Organization (WHO) updates from April 2024, globally, an estimated 6–7 million individuals, predominantly in Latin America, are infected with Trypanosoma cruzi, the parasite responsible for Chagas disease. While Chagas disease is gaining a more prominent global presence, it remains primarily concentrated in 21 endemic countries across continental Latin America. In addition, as per the same source, about 75 million individuals are identified as being at risk of Trypanosoma cruzi infection. This shows the significant high parasitic disease burden, which is expected to boost market growth over the study period.

In addition, the positive recommendations of the regulators for new antiparasitic drugs are expected to increase the usage of these products in the market. For instance, in February 2024, the European Medicines Agency (EMA) issued a favorable opinion for Fexinidazole Winthrop, marking it as one of the oral treatments for rhodesiense sleeping sickness caused by Trypanosoma brucei rhodesiense. These positive opinions may increase the demand for treating parasitic infections, boosting market growth over the forecast period.

However, the adverse effects and risks associated with antiparasitic drugs are expected to hamper the growth of the antiparasitic drugs market over the forecast period.

Antiparasitic Drugs Industry Segmentation

As per the scope of the report, antiparasitic drugs are used to treat various parasitic diseases, such as those caused by parasitic fungi, protozoa, helminths, ectoparasites, and amoeba. These drugs target and attack the parasitic agents of various infections and destroy or restrain their growth and development. 

The antiparasitic drugs market is segmented by drug type, route of administration, distribution channel, and geography. By drug type, the market is segmented into anthelmintics, antiprotozoals, and other drug types. By route of administration, the market is segmented into oral, injectable, and topical. By distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, and other distribution channels. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers market sizes and forecasts in terms of value (USD) for the above segments.